Your browser doesn't support javascript.
loading
Epigenetic modifications as targets to new therapies for Chronic Lymphocytic leukaemia - A preliminary study: PS186.
Ribau, B; Jorge, J; Alves, R; Ribeiro, P I; Gonçalves, A C; Carreira, I M; Sarmento-Ribeiro, A B.
Afiliação
  • Ribau B; Department of Chemistry, University of Aveiro, Portugal.
  • Jorge J; Laboratory of Oncobiology and Hematology (LOH), University Clinic of Hematology and Applied Molecular Biology, FMUC, Portugal.
  • Alves R; Laboratory of Oncobiology and Hematology (LOH), University Clinic of Hematology and Applied Molecular Biology, FMUC, Portugal.
  • Ribeiro PI; CIMAGO - Center of Investigation on Environment Genetics and Oncobiology, Faculty of Medicine, University of Coimbra, Portugal.
  • Gonçalves AC; Laboratory of Oncobiology and Hematology (LOH), University Clinic of Hematology and Applied Molecular Biology, FMUC, Portugal.
  • Carreira IM; Center for Neuroscience and Cell Biology, IBILI (CNC.IBILI), University of Coimbra, Portugal.
  • Sarmento-Ribeiro AB; CIMAGO - Center of Investigation on Environment Genetics and Oncobiology, Faculty of Medicine, University of Coimbra, Portugal.
Porto Biomed J ; 2(5): 223, 2017.
Article em En | MEDLINE | ID: mdl-32258725
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Porto Biomed J Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Porto Biomed J Ano de publicação: 2017 Tipo de documento: Article